emicizumab
emicizumab: 2 clinical trials tracked.
emicizumab evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about emicizumab, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (2)
A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Prophylaxis in Patients With Type 3 Von Willebrand Disease
Primary endpoint: Annualized Bleed Rate (ABR) for Treated Bleeds in the Randomized Arms
An Open-label, Single-arm Treatment Study to Investigate the Safety and Tolerability of Switching From Emicizumab to Fitusiran Prophylaxis in Male Participants Aged ≥12 Years of Age With Severe Hemophilia A, With or Without Inhibitors
Primary endpoint: Number of participants with Adverse events (AEs) during the fitusiran treatment